Global Synthetic DNA Market to Reach $10.3 Billion by 2030
The global market for Synthetic DNA estimated at US$2.6 Billion in the year 2022, is projected to reach a revised size of US$10.3 Billion by 2030, growing at a CAGR of 19% over the analysis period 2022-2030. Pharmaceuticals & Diagnostics, one of the segments analyzed in the report, is projected to record 21% CAGR and reach US$4.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Chemicals segment is readjusted to a revised 16.9% CAGR for the next 8-year period.The U.S. Market is Estimated at $697.3 Million, While China is Forecast to Grow at 26.4% CAGR
The Synthetic DNA market in the U.S. is estimated at US$697.3 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2030 trailing a CAGR of 26.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.3% and 15.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 13.3% CAGR.Select Competitors (Total 34 Featured) -
- Codexis, Inc.
- Creative Enzymes
- Cyrus Biotechnology Inc.
- Eurofins Scientific
- Integrated DNA Technologies, Inc.
- New England Biolabs
- Synthego Corporation
- Synthetic Genomics, Inc.
- TeselaGen
- Twist Bioscience
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Codexis, Inc.
- Creative Enzymes
- Cyrus Biotechnology Inc.
- Eurofins Scientific
- Integrated DNA Technologies, Inc.
- New England Biolabs
- Synthego Corporation
- Synthetic Genomics, Inc.
- TeselaGen
- Twist Bioscience
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 89 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 2.6 Billion |
Forecasted Market Value ( USD | $ 10.3 Billion |
Compound Annual Growth Rate | 18.8% |
Regions Covered | Global |